Fauci believes there could be three doses that are the COVID-19 vaccination standard

Three doses of COVID-19 vaccine could become the new normal for most peoplesaid Thursday Antoine Fauci, Chief Medical Officer of White House, during an information session.

A study in Israel revealed an impressive improvement in terms of protection between the recipients of three doses vaccine Pfizer Inc. and BioNTech SE, which is normally given in two doses, he said Fauci. If the improvements last, “the new routine regimen is most likely the three dose regimen“, noted.

The durability of immunity will be confirmed when the data is submitted to the Food and drug administrationadded Fauci.

Biden administration faces criticism on a plan announced last month to make the third dose available to Americans eight months after their second dose. Some critics have said the White House is ahead of US drug and public health authorities, who have yet to give the green light.

Health experts are still uncertain whether the covid-19 vaccines will be given regularly and repeatedly.like the annual flu shot.

For its part, the health agency of European Union noted that the application of third doses of COVID-19 vaccines this is not urgent. According to a report published by the European Center for Disease Prevention and Control (ECDC), not enough evidence to affirm that a reinforcement of a third dose is necessary and that, for the moment, the two-dose vaccination schedule is sufficiently comprehensive and effective.

“Based on the current evidence, there is no urgent need to administer booster doses of vaccines to full-regimen individuals in the general population.“Says the technical report. In order to comment on the subject, according to the same body, more information is needed on the duration of protection after complete inoculation.

However, the medical institution added that it was considering adding a third dose for people who meet the standard diet to a limited extent, this generates a lower amount of antibodies and immunity, or for those who are part of a risk group.

The European Medicines Agency informs that “is currently evaluating the supplemental dose data and will consider whether any updates to the product information are appropriate“Or negative, details should be included in the vaccine package insert, in the same way it will continue to review available information, which includes data from vaccination campaigns, reports from drug companies and other studies on the need for a booster dose.

The agency highlights how “fundamental” continue to apply measures such as distancing physical in society, hygiene hands and the use of masks when necessary, especially in high-risk settings, such as healthcare facilities or hospital wards with patients at risk for Covid-19.

Although there is not yet a clear conclusion on the third dose in the general population, the EMA remember that Member States ‘may consider preparatory plans’ to administer booster doses and additional doses.

(With information from Bloomberg)

KEEP READING